Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
Cell Death & Disease
Grassi, Ludovica L; Alfonsi, Romina R; Francescangeli, Federica F; Signore, Michele M; De Angelis, Maria Laura ML; Addario, Antonio A; Costantini, Manuela M; Flex, Elisabetta E; Ciolfi, Andrea A; Pizzi, Simone S; Bruselles, Alessandro A; Pallocca, Matteo M; Simone, Giuseppe G; Haoui, Mustapha M; Falchi, Mario M; Milella, Michele M; Sentinelli, Steno S; Di Matteo, Paola P; Stellacci, Emilia E; Gallucci, Michele M; Muto, Giovanni G; Tartaglia, Marco M; De Maria, Ruggero R; Bonci, Désirée D
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma.
British Journal Of Cancer
Xu, C-F CF; Johnson, T T; Garcia-Donas, J J; Choueiri, T K TK; Sternberg, C N CN; Davis, I D ID; Bing, N N; Deen, K C KC; Xue, Z Z; McCann, L L; Esteban, E E; Whittaker, J C JC; Spraggs, C F CF; Rodríguez-Antona, C C; Pandite, L N LN; Motzer, R J RJ
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
British Journal Of Cancer
Beuselinck, B B; Karadimou, A A; Lambrechts, D D; Claes, B B; Wolter, P P; Couchy, G G; Berkers, J J; Paridaens, R R; Schöffski, P P; Méjean, A A; Verkarre, V V; Lerut, E E; de la Taille, A A; Tourani, J-M JM; Bigot, P P; Linassier, C C; Négrier, S S; Berger, J J; Patard, J-J JJ; Zucman-Rossi, J J; Oudard, S S